<<I’m not sure which circles you’re referring to.>>
I was referring to companies like DNA, MEDX, Genmab and Centocor, who all are heavily involved with monoclonal antibodies and who are working with Biolex.
Biolexis' peers' rating of the technology seems to be pretty high.